---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-033302"
form_type: "8-K"
ticker: "NAGE"
cik: "0001386570"
company_name: "Niagen Bioscience, Inc."
filed_at: "2025-06-27T23:59:59+00:00"
generated_at: "2026-05-18T15:41:06.836690+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Stockholders approve 4.75M share increase to equity plan and new ESPP at annual meeting

## Summary
- Amendment to 2017 Equity Incentive Plan adds 4,750,000 shares; approved by 53,046,229 votes for.
- Employee Stock Purchase Plan approved: 650,000 shares authorized, purchased at 85% of lower of grant/ purchase price.
- All eight director nominees elected; Steven Rubin received 12.4M withheld votes, others largely unanimous.
- Crowe LLP ratified as independent auditor for FY2025 with 63.4M votes for.
- Advisory say-on-pay proposal passed with 54.9M for vs 1.2M against.

## SEC filing metadata
- accession: 0001628280-25-033302
- form_type: 8-K
- ticker: NAGE
- cik: 0001386570
- company_name: Niagen Bioscience, Inc.
- filed_at: 2025-06-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1386570/000162828025033302/0001628280-25-033302-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1386570/000162828025033302/cdxc-20250624.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-033302
- JSON: https://secwatch.observer/filing/0001628280-25-033302.json
- Plain text: https://secwatch.observer/filing/0001628280-25-033302.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.